Fundraising
Non-Dilutive Funding
Last updated
Quick Answer
Capital sources that don't require giving up equity — including grants, loans, revenue-based financing, and government programs.
What it is
Non-dilutive funding is any capital source that doesn't reduce founders' equity ownership. Types: Government grants (SBIR/STTR grants for deep-tech startups, up to $2M with no equity required), revenue-based financing (investors receive a percentage of monthly revenue until a multiple is repaid — no fixed equity dilution), venture debt (loans from specialized lenders — requires repayment but no equity, only warrants), bank loans (rare for early-stage startups without assets), and customer prepayments or annual subscription payments. Non-dilutive funding is particularly valuable for founders who want to grow before taking on expensive equity capital, or for companies in capital-intensive sectors where grants can fund initial R&D.
In Practice
MedTech startup BioFlow raised $500K in non-dilutive funding before their Series A: a $200K SBIR grant from the NIH for clinical trials, a $150K state innovation grant, and $150K in revenue-based financing from a specialized fund that takes 8% of monthly revenue until they've received $225K back. This $500K allowed BioFlow to extend their runway by 8 months and hit key clinical milestones, ultimately raising their Series A at a $15M valuation instead of the $8M they would have commanded earlier. The founders kept an extra 7% equity by avoiding premature dilution.
Operational context
What good looks like
The term is tied to a real workflow, not just a definition.
Ownership, timing, and evidence are clear.
The reader can tell what decision the concept supports.
Related terms point to the next useful explanation.
Why It Matters
Non-dilutive funding can dramatically improve your equity position and negotiating leverage with VCs by extending runway and hitting key milestones before raising. Many founders leave money on the table by not exploring grants, government programs, and alternative financing that could delay or eliminate the need for equity funding. However, non-dilutive often comes with strings attached—revenue share, restrictive covenants, or operational requirements that can limit flexibility. The key is matching funding type to company stage and needs.
VC Beast Take
Too many founders treat non-dilutive funding as 'free money' without reading the fine print. Revenue-based financing can be more expensive than equity if your growth explodes, and government grants often come with bureaucratic overhead that kills startup speed. The sweet spot is using non-dilutive funding strategically to bridge between equity rounds or fund specific projects, not as a primary growth capital strategy.
Term Family
Related concepts
Further Reading
Share Dilution Explained: Formula, Examples, and How to Protect Your Equity
The dilution formula every founder needs to know, three worked examples from simple to multi-round, how option pools really work, and practical strategies to protect your ownership stake.
How to Negotiate a Term Sheet as a First-Time Founder
Your first term sheet is exciting and terrifying. Know what's negotiable, what's standard, and the practical tactics for pushing back on liquidation preferences, board seats, and protective provisions.
When Should a Startup Raise Venture Capital?
Not every startup should raise VC. The timing, market signals, and traction benchmarks that indicate you're ready — plus the honest case for when bootstrapping is the smarter path.
Defense Tech Venture Capital: How the Category Exploded
Defense tech VC investment surged from $8B to over $30B between 2019 and 2023. Here's what drove the explosion — and what risks remain as the category matures.
Biotech Venture Capital: Navigating Long Timelines and Binary Outcomes
Biotech VC is a different animal: 10-year timelines, binary FDA outcomes, and massive capital requirements. Here's how the best biotech fund managers structure for success.
The Real Cost of Taking VC Money
VC funding isn't free money — it's an exchange of control, optionality, and upside that most founders don't fully price until it's too late.
Comparisons
Frequently Asked Questions
What is Non-Dilutive Funding in venture capital?
Non-dilutive funding is any capital source that doesn't reduce founders' equity ownership. Types: Government grants (SBIR/STTR grants for deep-tech startups, up to $2M with no equity required), revenue-based financing (investors receive a percentage of monthly revenue until a multiple is repaid —...
Why is Non-Dilutive Funding important for startups?
Understanding Non-Dilutive Funding is critical for founders navigating the fundraising process. It directly impacts deal terms, valuation, and the relationship between founders and investors.
What category does Non-Dilutive Funding fall under in VC?
Non-Dilutive Funding falls under the fundraising category in venture capital. This area covers concepts related to how startups and funds raise capital from investors.
Newsletter
The VC Beast Brief
Fund operations, one problem a week — plus benchmarks from 75,000+ SEC filings. Every Tuesday.
The VC Beast Brief
The weekly brief for emerging managers and founders
Weekly intelligence on fundraising, VC strategy, and the signals that matter. Every Tuesday, free.
Related Tools
Archstone
Run your fund like an institution.